metformin zentiva 850 mg tabletti, kalvopäällysteinen
zentiva, k.s. - metformin hydrochloride - tabletti, kalvopäällysteinen - 850 mg - metformiini
metformin zentiva 500 mg tabletti, kalvopäällysteinen
zentiva, k.s. - metformin hydrochloride - tabletti, kalvopäällysteinen - 500 mg - metformiini
zolsketil pegylated liposomal
accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.
xofigo
bayer ag - radium (223ra) dichloride - prostatiset kasvaimet - terapeuttiset radiofarmaseuttiset valmisteet - xofigo on tarkoitettu aikuisilla, joilla on kastrointuntuvaa eturauhassyöpää, oireeton luumetastaaseja eikä tunnettuja viskeraalisia metastaaseja.
cisordinol 2 mg tabletti, kalvopäällysteinen
h. lundbeck a/s - zuclopenthixol dihydrochloride - tabletti, kalvopäällysteinen - 2 mg - tsuklopentiksoli
cisordinol 10 mg tabletti, kalvopäällysteinen
h. lundbeck a/s - zuclopenthixol dihydrochloride - tabletti, kalvopäällysteinen - 10 mg - tsuklopentiksoli
cisordinol 25 mg tabletti, kalvopäällysteinen
h. lundbeck a/s - zuclopenthixol dihydrochloride - tabletti, kalvopäällysteinen - 25 mg - tsuklopentiksoli
betaserc 8 mg tabletti
viatris oy - betahistine dihydrochloride - tabletti - 8 mg - betahistiini
zyrtec 10 mg tabletti, kalvopäällysteinen
ucb pharma oy finland - cetirizine dihydrochloride - tabletti, kalvopäällysteinen - 10 mg - setiritsiini
betaserc 16 mg tabletti
viatris oy - betahistine dihydrochloride - tabletti - 16 mg - betahistiini